Results 271 to 280 of about 200,281 (336)

Simultaneous onset of systemic sclerosis and light chain amyloidosis: the first report of a case report and review of the literature. [PDF]

Rheumatol Int
Colangelo A, Tromby F, Agliani E, Bruno L, Cafaro G, Crusco F, Mengoni A, Zuchi C, Gerli R, Bartoloni E, Perricone C.   +10 more
europepmc   +1 more source

MCV/Q, Medical College of Virginia Quarterly, Vol. 14 No. 3 [PDF]

, 1978

core   +1 more source

Olmesartan‐induced gastritis with no lower gastrointestinal symptoms: A case report

DEN Open, Volume 6, Issue 1, April 2026.
Abstract A 74‐year‐old man with decreased appetite, weight, and heartburn was referred to our hospital. His medications included olmesartan. Esophagogastroduodenoscopy (EGD) revealed antral‐dominant erosive gastritis and nodular mucosa. A gastric biopsy revealed inflammatory cell infiltration.
Satoshi Kosaka, Miki Kamiyama, Masahiro Ochi   +2 more
wiley   +1 more source

Cardiac magnetic resonance imaging and cardiac scintigraphy in the diagnosis of cardiac amyloidosis: A meta-analysis of 4866 patients. [PDF]

J Mol Cell Cardiol Plus
Balata M, M Attia A, Gbreel MI, Elsmaan M, Hassan M, Rapeanu P, Marinova M, Becher MU, Ebeid I, Ortak J, Ince H.   +10 more
europepmc   +1 more source

An autopsy case of primary amyloidosis associated with the development of jaundice and rupture of liver cavernous hemangioma - With reference to the results of analysis of amyloid protein.

, 1986
Masaji Nambu, S Maeda, Toshihiko Iijima
openalex   +2 more sources

Time‐resolved mapping of myocardial stiffness using 2D multifrequency spiral MR elastography with and without external vibration

Magnetic Resonance in Medicine, Volume 94, Issue 6, Page 2421-2434, December 2025.
Abstract Purpose There is a clinical need for stiffness mapping of the heart; however, current cardiac magnetic resonance elastography (cMRE) has limited spatiotemporal resolution. Therefore, we developed 2D spiral multifrequency MRE of the human heart and conducted a study to analyze the consistency and reproducibility of motion‐encoding and stiffness
Matthias S. Anders, Carsten Warmuth, Tom Meyer, Helge Herthum, Mehrgan Shahryari, Jakob Schattenfroh, Corona Metz, Jan Bieling, Josef Pfeuffer, Simon Veldhoen, Jeanette Schulz‐Menger, Tobias Schaeffter, Jing Guo, Heiko Tzschätzsch, Ingolf Sack   +14 more
wiley   +1 more source

Prediction of Cardiac Transthyretin Amyloidosis: Electrocardiographic Parameters and the Ratio of Posterior Wall Thickness to the Minimum QRS Complex Voltage in Limb Leads. [PDF]

Biomedicines
Gawor-Prokopczyk M, Lipowska M, Sioma A, Chrustowicz A, Henzel J, Grzybowski J, Szczygieł J, Wójcik A, Konka M, Kowalik E, Teresińska A, Mazurkiewicz Ł.   +11 more
europepmc   +1 more source

Silver-positive kidney AL amyloidosis

Francesco Fontana, Gaetano Alfano, Laura Verga, Riccardo Magistroni, Gabriele Donati   +4 more
openalex   +2 more sources

From Trials to Practice: A 2025 Review of Idecabtagene Vicleucel and Ciltacabtagene Autoleucel Efficacy Across Clinical Studies and Real‐World Evidence

European Journal of Haematology, Volume 115, Issue 6, Page 533-546, December 2025.
ABSTRACT B‐cell maturation antigen (BCMA)‐directed chimeric antigen receptor (CAR) T‐cell therapies have revolutionized the approach and management of relapsed/refractory multiple myeloma (RRMM), and as of 2025, idecabtagene vicleucel (ide‐cel) and ciltacabtagene autoleucel (cilta‐cel) are the only BCMA‐targeted CAR T‐cell therapies approved by the FDA.
Hector Garcia Pleitez, Sakditad Saowapa, Andrea Ortiz Maldonado, Chanakarn Kanitthamniyom, Diego Olavarria Bernal, Lukman Tijani   +5 more
wiley   +1 more source

A Rare Case of Systemic Amyloidosis Involving the Thyroid in a Young Patient. [PDF]

J Clin Med
Kasprzak OJ, Stępińska K, Kiedrowska K, Błaszkowski T, Kudrymska A, Sikora S, Miernik M, Romanowski M.   +7 more
europepmc   +1 more source